tirzepatide rutherfordton semaglutide Medical Weight Loss: A Key to Lasting Health & Change Microdosing Tirzepatide Program | No

Mounjaro produces 15-22% weight loss vs 8% with Saxenda in clinical trials

Consistent reductions were seen for patients stratified by gender, age group, race and in patients with and without T2D

This study compared the cardiovascular protective effects of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) versus sodium-glucose cotransporter-2 (SGLT2) inhibitors in this population

We utilize science to help to achieve ones health goals in the form of weight loss medications: Ozempic, Rybelsus, Wegovy, Mounjaro, Zepbound

First non-insulin drug for pediatric use approved in nearly 20 years.

Shop GLP-1-friendly protein shakes and drinks formulated to support appetite control, smooth digestion, and sustained energy